Santhera Pharmaceuticals Holding AG (SPHDF)
USD 9.42
(0.0%)
USD 9.42
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 56.14 Million | -32.27 Million | -40.94 Million | -49.22 Million | 2.67 Million | -38.41 Million |
| Net Income | 65.06 Million | -76.86 Million | -60.86 Million | -76.54 Million | -19.59 Million | -54.96 Million |
| Depreciation & Amortization | 3.61 Million | 3.94 Million | 4.08 Million | 8.07 Million | 4.92 Million | 3.79 Million |
| Deferred income taxes | - | -13.34 Million | -10.92 Million | -19.17 Million | - | - |
| Stock-based compensation | 5.99 Million | 5.45 Million | 2.76 Million | 3.02 Million | 6.25 Million | - |
| Change in working capital | -6.26 Million | 1.5 Million | 1.93 Million | 3.67 Million | 5.96 Million | 6.04 Million |
| Other non-cash items | 958.5 Thousand | 47.02 Million | 22.05 Million | 31.72 Million | 21.23 Million | 14.3 Million |
| Investing Cash Flow | -21.43 Million | -4.25 Million | 75.63 Thousand | 1.76 Million | 2.88 Million | -5.99 Million |
| Investments in PPE | -28.2 Million | -4.27 Million | -16.44 Thousand | -38.46 Thousand | -236.48 Thousand | -21.95 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 6.76 Million | 25.95 Thousand | 92.07 Thousand | 1.8 Million | 3.11 Million | 15.95 Million |
| Other Investing Activities | -21.34 Million | 1.00 | -1.00 | -1.00 | 3 Million | - |
| Financing Cash Flow | -203.1 Thousand | 15.13 Million | 50.44 Million | 26.18 Million | 4.26 Million | 20.94 Million |
| Debt repayment | -21.34 Million | -15.73 Million | -35.39 Million | -27.78 Million | -1.09 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -61.38 Thousand | -1.04 Million | -1.89 Million | -3.46 Million |
| Common Stock Issuance | 18.91 Million | 217.36 Thousand | 19.69 Million | 739.86 Thousand | 7.25 Million | 24.4 Million |
| Other Financing Activities | 3.07 Million | -125.44 Thousand | -3.76 Million | -79.18 Thousand | 7.25 Million | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -6.27 Million | 1.5 Million | 1.93 Million | 3.66 Million | 5.96 Million | - |
| Cash at beginning of period | 1.46 Million | 23.24 Million | 14.04 Million | 33.93 Million | 25.33 Million | 49.45 Million |
| Cash at end of period | 36.07 Million | 1.46 Million | 23.24 Million | 14.04 Million | 33.93 Million | 25.33 Million |
| Capital Expenditure | -28.2 Million | -4.27 Million | -16.44 Thousand | -38.46 Thousand | -236.48 Thousand | -21.95 Million |
| Effect of forex changes on cash | -39 Thousand | -73 Thousand | 65 Thousand | -150 Thousand | -126 Thousand | - |
| Net cash flow / Change in cash | 34.6 Million | -21.78 Million | 9.2 Million | -19.89 Million | 8.6 Million | -24.12 Million |
| Free Cash Flow | 27.94 Million | -36.55 Million | -40.96 Million | -49.26 Million | 2.44 Million | -60.36 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -8.49 Million | -8.46 Million | 46.43 Million | 65.06 Million | 42.66 Million | -26.05 Million |
| Depreciation & Amortization | 1.54 Million | 1.53 Million | 703.26 Thousand | 3.61 Million | 646.17 Thousand | 2.03 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 1.44 Million | 1.43 Million | 2.43 Million | 5.99 Million | 2.23 Million | 1.06 Million |
| Change in working capital | -1.05 Million | -1.04 Million | -5.35 Million | -6.26 Million | -4.91 Million | 4.15 Million |
| Other non-cash items | -1.94 Million | -1.93 Million | -6.99 Million | 958.5 Thousand | -6.42 Million | 6.78 Million |
| Investing Cash Flow | 5565.88 | 5543.97 | -14.1 Million | -21.43 Million | -12.95 Million | 6.34 Million |
| Investments in PPE | -40.07 Thousand | -39.91 Thousand | -53.5 Thousand | -28.2 Million | -49.15 Thousand | - |
| Acquisitions | - | - | -6.74 Million | - | - | 6.34 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 91.2 Thousand | - | 6.76 Million | 6.76 Million | - | 3350.10 |
| Other Investing Activities | 45.64 Thousand | 45.46 Thousand | -14.05 Million | -21.34 Million | -12.91 Million | 3.17 Million |
| Financing Cash Flow | -199.25 Thousand | -198.47 Thousand | -6.03 Million | -203.1 Thousand | -5.54 Million | 11.14 Million |
| Debt repayment | - | - | -30.49 Million | -21.34 Million | - | -8.59 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 15.67 Million | 18.91 Million | - | 3.04 Million |
| Other Financing Activities | -199.25 Thousand | -198.47 Thousand | -6.03 Million | 3.07 Million | -5.54 Million | -113.9 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.05 Million | -1.04 Million | -5.35 Million | -6.27 Million | -4.91 Million | 2.07 Million |
| Cash at beginning of period | 36.07 Million | - | 1.86 Million | 1.46 Million | -0.73 | 1.46 Million |
| Cash at end of period | 18.34 Million | -7.69 Million | 36.07 Million | 36.07 Million | 15.67 Million | 1.86 Million |
| Capital Expenditure | -40.07 Thousand | -39.91 Thousand | -53.5 Thousand | -28.2 Million | -49.15 Thousand | - |
| Effect of forex changes on cash | 975.14 Thousand | 971.3 Thousand | -33.88 Thousand | -39 Thousand | -31.13 Thousand | 10.05 Thousand |
| Net cash flow / Change in cash | -17.72 Million | -7.69 Million | 34.2 Million | 34.6 Million | 15.67 Million | 406.22 Thousand |
| Free Cash Flow | -8.54 Million | -8.51 Million | 37.17 Million | 27.94 Million | 34.15 Million | -17.15 Million |
RKIGF
VRG
ESSARSHPNG
WANSF
RHCGF
HS2